{
    "nctId": "NCT00530101",
    "briefTitle": "The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity",
    "officialTitle": "The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 3,
    "primaryOutcomeMeasure": "The purpose of this research study is to evaluate MR imaging in subjects receiving doxorubicin chemotherapy to see if MR can detect heart damage as well as or better than MUGA scans.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Subject must have breast cancer and undergoing radiation treatment with a likelihood of developing cardiotoxicity.\n\nExclusion Criteria:\n\n* Healthy subjects\n* Males\n* Subjects under the age of 18",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}